Stoke Therapeutics Inc buy BTIG Research
Start price
18.08.25
/
50%
€15.60
Target price
18.08.26
€23.93
Performance (%)
67.50%
Price
20:49
€26.13
Summary
This prediction is currently active. The BUY prediction by BTIG_Research for Stoke Therapeutics Inc has seen massive gains of 67.50%. This prediction currently runs until 18.08.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 8.507% | 8.507% |
| iShares Core DAX® | 1,17 % | 4,37 % |
| iShares Nasdaq 100 | 2,74 % | 12,45 % |
| iShares Nikkei 225® | 4,95 % | 11,54 % |
| iShares S&P 500 | 1,40 % | 6,63 % |
Comments by BTIG_Research for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) was given a new $28.00 price target on by analysts at BTIG Research. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by BTIG_Research for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€27.17
11.05.26
11.05.26
€33.17
11.05.27
11.05.27
-1.80%
20:49
20:49
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€27.60
19.03.26
19.03.26
€33.95
19.03.27
19.03.27
-5.33%
20:49
20:49
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€19.00
05.11.25
05.11.25
€33.93
05.11.26
05.11.26
37.53%
20:49
20:49
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€26.60
14.10.25
14.10.25
€33.70
14.10.26
14.10.26
-1.77%
20:49
20:49